{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T16:12:22Z","timestamp":1784045542510,"version":"3.55.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:00:00Z","timestamp":1779148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:00:00Z","timestamp":1783987200000},"content-version":"vor","delay-in-days":56,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Guangdong Medical Science and Technology Research Fund Project of China","award":["A2025284"],"award-info":[{"award-number":["A2025284"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82573410"],"award-info":[{"award-number":["82573410"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shenzhen Science and Technology Program","award":["JCYJ20230807110708018"],"award-info":[{"award-number":["JCYJ20230807110708018"]}]},{"name":"Shenzhen Science and Technology Program","award":["RCYX20231211090346060 and JCYJ20240813150403005"],"award-info":[{"award-number":["RCYX20231211090346060 and JCYJ20240813150403005"]}]},{"name":"Shenzhen Medical Research Fund","award":["D2301010 and D2503009"],"award-info":[{"award-number":["D2301010 and D2503009"]}]},{"DOI":"10.13039\/501100021171","name":"Guangdong Basic and Applied Basic Research Foundation","doi-asserted-by":"crossref","award":["2023A1515010690 and 2025A1515011060"],"award-info":[{"award-number":["2023A1515010690 and 2025A1515011060"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"DOI":"10.1186\/s12951-026-04556-2","type":"journal-article","created":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T15:26:07Z","timestamp":1779204367000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Rhein-Mn coordination nanomedicine for peritoneal metastatic colorectal cancer: synergistic mitochondrial targeting, immunogenic cell death, and reverses immunosuppression"],"prefix":"10.1186","volume":"24","author":[{"given":"Yingfei","family":"Wen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miaojuan","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyi","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiran","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodie","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binbin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shangbo","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Yamakawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiqiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingqi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiye","family":"Chi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,19]]},"reference":[{"issue":"5","key":"4556_CR1","first-page":"423","volume":"26","author":"WQ Luo","year":"2023","unstructured":"Luo WQ, Ye L, Cai GX. Molecular mechanism and treatment strategy of colorectal cancer peritoneal metastasis. Zhonghua Wei Chang Wai Ke Za Zhi. 2023;26(5):423\u20138.","journal-title":"Zhonghua Wei Chang Wai Ke Za Zhi"},{"key":"4556_CR2","doi-asserted-by":"publisher","unstructured":"Schultz KS, Bansal VV, Wach MM, Bhutiani N, Godley FAt, Wang JJ et al. Consensus guideline for the management of colorectal cancer with peritoneal metastases. Ann Surg Oncol. 2025. https:\/\/doi.org\/10.1245\/s10434-025-17363-0","DOI":"10.1245\/s10434-025-17363-0"},{"issue":"1","key":"4556_CR3","doi-asserted-by":"publisher","first-page":"3669","DOI":"10.1038\/s41467-025-58999-6","volume":"16","author":"J Saris","year":"2025","unstructured":"Saris J, Li Yim AYF, Bootsma S, Lenos KJ, Franco Fernandez R, Khan HN, et al. Peritoneal resident macrophages constitute an immunosuppressive environment in peritoneal metastasized colorectal cancer. Nat Commun. 2025;16(1):3669.","journal-title":"Nat Commun"},{"key":"4556_CR4","doi-asserted-by":"publisher","first-page":"1661545","DOI":"10.3389\/fimmu.2025.1661545","volume":"16","author":"P Ouyang","year":"2025","unstructured":"Ouyang P, Zhang J, He X, Yang C, Zeng D, Xu D. Infiltration characteristics and regulatory mechanisms of CD8(+) T lymphocytes in solid tumors: spatial distribution, biological functions, and interactions with the immune microenvironment. Front Immunol. 2025;16:1661545.","journal-title":"Front Immunol"},{"issue":"14","key":"4556_CR5","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.2217\/imt-2020-0026","volume":"12","author":"Y Kamal","year":"2020","unstructured":"Kamal Y, Schmit SL, Frost HR, Amos CI. The tumor microenvironment of colorectal cancer metastases: opportunities in cancer immunotherapy. Immunotherapy. 2020;12(14):1083\u2013100.","journal-title":"Immunotherapy"},{"key":"4556_CR6","doi-asserted-by":"publisher","first-page":"1125868","DOI":"10.3389\/fonc.2023.1125868","volume":"13","author":"S Breusa","year":"2023","unstructured":"Breusa S, Zilio S, Catania G, Bakrin N, Kryza D, Lollo G. Localized chemotherapy approaches and advanced drug delivery strategies: a step forward in the treatment of peritoneal carcinomatosis from ovarian cancer. Front Oncol. 2023;13:1125868.","journal-title":"Front Oncol"},{"issue":"9","key":"4556_CR7","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1080\/17425247.2021.1896493","volume":"18","author":"P Wang","year":"2021","unstructured":"Wang P, Qu X, Che X, Luo Q, Tang X, Liu Y. Pharmaceutical strategies in improving anti-tumour efficacy and safety of intraperitoneal therapy for peritoneal metastasis. Expert Opin Drug Deliv. 2021;18(9):1193\u2013210.","journal-title":"Expert Opin Drug Deliv"},{"issue":"4","key":"4556_CR8","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s10585-023-10212-y","volume":"40","author":"A Rijken","year":"2023","unstructured":"Rijken A, van de Vlasakker VCJ, Simkens GA, Rovers KP, van Erning FN, Koopman M, et al. Primary tumor resection or systemic treatment as palliative treatment for patients with isolated synchronous colorectal cancer peritoneal metastases in a nationwide cohort study. Clin Exp Metastasis. 2023;40(4):289\u201398.","journal-title":"Clin Exp Metastasis"},{"issue":"1","key":"4556_CR9","doi-asserted-by":"publisher","first-page":"4045","DOI":"10.1038\/s41598-025-88555-7","volume":"15","author":"Y Qiu","year":"2025","unstructured":"Qiu Y, Cao N, Meng D, Yuan J, Zhu Y. Survival and risk factors for metastatic colorectal cancer patients with a history of prior malignancy. Sci Rep. 2025;15(1):4045.","journal-title":"Sci Rep"},{"issue":"10","key":"4556_CR10","doi-asserted-by":"publisher","first-page":"2374","DOI":"10.3390\/molecules29102374","volume":"29","author":"Y Chen","year":"2024","unstructured":"Chen Y, Fan W, Zhao Y, Liu M, Hu L, Zhang W. Progress in the regulation of immune cells in the tumor microenvironment by bioactive compounds of traditional chinese medicine. Molecules. 2024;29(10):2374.","journal-title":"Molecules"},{"issue":"2","key":"4556_CR11","first-page":"270","volume":"6","author":"CN Minh Hoang","year":"2025","unstructured":"Minh Hoang CN, Nguyen SH, Tran MT. Nanoparticles in cancer therapy: Strategies to penetrate and modulate the tumor microenvironment \u2013 A review. Smart Mater Med. 2025;6(2):270\u201384.","journal-title":"Smart Mater Med"},{"issue":"22","key":"4556_CR12","doi-asserted-by":"publisher","first-page":"7086","DOI":"10.1039\/D5NA00390C","volume":"7","author":"J Bhatt","year":"2025","unstructured":"Bhatt J, Jain S, Gupta S, Bhatia DD. Nanomedicine revolutionizing cancer immunotherapy: recent advancements in nanotechnological strategies and applications. Nanoscale Adv. 2025;7(22):7086\u2013108.","journal-title":"Nanoscale Adv"},{"issue":"12","key":"4556_CR13","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.3390\/ph17121665","volume":"17","author":"Y Fu","year":"2024","unstructured":"Fu Y, Yang L, Liu L, Kong L, Sun H, Sun Y, et al. Rhein: An updated review concerning its biological activity, pharmacokinetics, structure optimization, and future pharmaceutical applications. Pharmaceuticals (Basel). 2024;17(12):1665.","journal-title":"Pharmaceuticals (Basel)"},{"issue":"6","key":"4556_CR14","first-page":"981","volume":"61","author":"AM Trofin","year":"2025","unstructured":"Trofin AM, Scripcariu DV, Filipiuc SI, Neagu AN, Filipiuc LE, Tamba BI, et al. From nature to nanomedicine: enhancing the antitumor efficacy of rhein, curcumin, and resveratrol. Med (Kaunas). 2025;61(6):981.","journal-title":"Med (Kaunas)"},{"issue":"11","key":"4556_CR15","doi-asserted-by":"publisher","first-page":"4909","DOI":"10.7150\/thno.107812","volume":"15","author":"Z Zhang","year":"2025","unstructured":"Zhang Z, Tang S, Qi M, Zhao H, Wu M, Huang SW. Mitochondria-targeting natural product rhein conjugated with dichloroacetate as the dual inhibitor of glycolysis and oxidative phosphorylation to off energize cancer cells and induce ROS storm. Theranostics. 2025;15(11):4909\u201329.","journal-title":"Theranostics"},{"issue":"3","key":"4556_CR16","doi-asserted-by":"publisher","first-page":"345","DOI":"10.3390\/chemistry6030020","volume":"6","author":"Z-J Xu","year":"2024","unstructured":"Xu Z-J, Wang W, Huang S-W. The conjugate of rhein\u2013artesunate for inducing immunogenic cell death to prepare cancer vaccine and suppress tumor growth. Chemistry. 2024;6(3):345\u201360.","journal-title":"Chemistry"},{"key":"4556_CR17","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.actbio.2024.03.030","volume":"180","author":"X Zhu","year":"2024","unstructured":"Zhu X, Xie L, Tian J, Jiang Y, Song E, Song Y. A multi-mode Rhein-based nano-platform synergizing ferrotherapy\/chemotherapy-induced immunotherapy for enhanced tumor therapy. Acta Biomater. 2024;180:383\u201393.","journal-title":"Acta Biomater"},{"issue":"24","key":"4556_CR18","doi-asserted-by":"publisher","first-page":"7677","DOI":"10.3390\/ma14247677","volume":"14","author":"L Berta","year":"2021","unstructured":"Berta L, Coman NA, Rusu A, Tanase C. A review on plant-mediated synthesis of bimetallic nanoparticles, Characterisation and Their Biological Applications. Mater (Basel). 2021;14(24):7677.","journal-title":"Mater (Basel)"},{"issue":"7","key":"4556_CR19","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.3390\/pharmaceutics15072003","volume":"15","author":"IH Suliman","year":"2023","unstructured":"Suliman IH, Kim K, Chen W, Kim Y, Moon JH, Son S, et al. Metal-Based nanoparticles for cancer metalloimmunotherapy. Pharmaceutics. 2023;15(7):2003.","journal-title":"Pharmaceutics"},{"key":"4556_CR20","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.jconrel.2024.09.008","volume":"375","author":"K Yuan","year":"2024","unstructured":"Yuan K, Zhang C, Pan X, Hu B, Zhang J, Yang G. Immunomodulatory metal-based biomaterials for cancer immunotherapy. J Control Release. 2024;375:249\u201368.","journal-title":"J Control Release"},{"issue":"11","key":"4556_CR21","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1038\/s41422-020-00395-4","volume":"30","author":"M Lv","year":"2020","unstructured":"Lv M, Chen M, Zhang R, Zhang W, Wang C, Zhang Y, et al. Manganese is critical for antitumor immune responses via cGAS-STING and improves the efficacy of clinical immunotherapy. Cell Res. 2020;30(11):966\u201379.","journal-title":"Cell Res"},{"issue":"5","key":"4556_CR22","doi-asserted-by":"publisher","first-page":"e2310979","DOI":"10.1002\/adma.202310979","volume":"36","author":"S Huang","year":"2024","unstructured":"Huang S, Gao Y, Li H, Wang R, Zhang X, Wang X, et al. Manganese@Albumin nanocomplex and its assembled nanowire activate TLR4-dependent signaling cascades of macrophages. Adv Mater. 2024;36(5):e2310979.","journal-title":"Adv Mater"},{"key":"4556_CR23","doi-asserted-by":"publisher","first-page":"1487376","DOI":"10.3389\/fonc.2024.1487376","volume":"14","author":"M Simonsen","year":"2024","unstructured":"Simonsen M, Mendoza L\u00f3pez RV, Maistro S, Ikeoka LT, Pereira GFL, Lug\u00e3o AB, et al. Peritoneal chemotherapy delivery systems for ovarian cancer treatment: systematic review of animal models. Front Oncol. 2024;14:1487376.","journal-title":"Front Oncol"},{"issue":"2","key":"4556_CR24","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1515\/pp-2017-0010","volume":"2","author":"E de Bree","year":"2017","unstructured":"de Bree E, Michelakis D, Stamatiou D, Romanos J, Zoras O. Pharmacological principles of intraperitoneal and bidirectional chemotherapy. Pleura Peritoneum. 2017;2(2):47\u201362.","journal-title":"Pleura Peritoneum"},{"key":"4556_CR25","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.jconrel.2025.01.035","volume":"380","author":"G Murphy","year":"2025","unstructured":"Murphy G, Brayden DJ, Cheung DL, Liew A, Fitzgerald M, Pandit A. Albumin-based delivery systems: Recent advances, challenges, and opportunities. J Control Release. 2025;380:375\u201395.","journal-title":"J Control Release"},{"issue":"1","key":"4556_CR26","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1186\/s12951-021-00896-3","volume":"19","author":"E Kianfar","year":"2021","unstructured":"Kianfar E. Protein nanoparticles in drug delivery: animal protein, plant proteins and protein cages, albumin nanoparticles. J Nanobiotechnol. 2021;19(1):159.","journal-title":"J Nanobiotechnol"},{"issue":"44","key":"4556_CR27","doi-asserted-by":"publisher","first-page":"9123","DOI":"10.1039\/D1TB01837J","volume":"9","author":"N Joshi","year":"2021","unstructured":"Joshi N, Liu D, Dickson KA, Marsh DJ, Ford CE, Stenzel MH. An organotypic model of high-grade serous ovarian cancer to test the anti-metastatic potential of ROR2 targeted Polyion complex nanoparticles. J Mater Chem B. 2021;9(44):9123\u201335.","journal-title":"J Mater Chem B"},{"issue":"2","key":"4556_CR28","first-page":"100549","volume":"8","author":"TPH Hutapea","year":"2023","unstructured":"Hutapea TPH, Madurani KA, Syahputra MY, Hudha MN, Asriana AN, Suprapto, et al. Albumin: Source, preparation, determination, applications, and prospects. J Science: Adv Mater Devices. 2023;8(2):100549.","journal-title":"J Science: Adv Mater Devices"},{"key":"4556_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-026-04308-2","author":"Y Cui","year":"2026","unstructured":"Cui Y, Niu Q, Li Z, Jiang G, Zhao D, Luo C, et al. Copper-rhein nanozymes induce bacterial activation-exhaustion death for the treatment of bacterial pneumonia and infected wounds. J Nanobiotechnol. 2026. https:\/\/doi.org\/10.1186\/s12951-026-04308-2.","journal-title":"J Nanobiotechnol"},{"key":"4556_CR30","doi-asserted-by":"publisher","first-page":"758268","DOI":"10.3389\/fonc.2021.758268","volume":"11","author":"Q Jiang","year":"2021","unstructured":"Jiang Q, Du K, Jiang Y, Liu Y, Han C, Yin Z, et al. Photostable red-emitting fluorescent rhein-magnesium(\u2161) coordination polymer nanodot-based nanostructures with a large stokes shift for imaging mitochondria in cancer cell. Front Oncol. 2021;11:758268.","journal-title":"Front Oncol"},{"issue":"1","key":"4556_CR31","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1186\/s12951-024-02981-9","volume":"22","author":"X Liu","year":"2024","unstructured":"Liu X, Liu S, Jin X, Liu H, Sun K, Wang X, et al. An encounter between metal ions and natural products: natural products-coordinated metal ions for the diagnosis and treatment of tumors. J Nanobiotechnol. 2024;22(1):726.","journal-title":"J Nanobiotechnol"},{"issue":"13","key":"4556_CR32","doi-asserted-by":"publisher","first-page":"11432","DOI":"10.1021\/acs.chemrev.1c01042","volume":"122","author":"H Geng","year":"2022","unstructured":"Geng H, Zhong QZ, Li J, Lin Z, Cui J, Caruso F, et al. Metal ion-directed functional metal-phenolic materials. Chem Rev. 2022;122(13):11432\u201373.","journal-title":"Chem Rev"},{"key":"4556_CR33","doi-asserted-by":"publisher","first-page":"114927","DOI":"10.1016\/j.colsurfb.2025.114927","volume":"255","author":"ZW Richter-Bisson","year":"2025","unstructured":"Richter-Bisson ZW, Hedberg YS. Revisiting the Vroman effect: Mechanisms of competitive protein exchange on surfaces. Colloids Surf B. 2025;255:114927.","journal-title":"Colloids Surf B"},{"key":"4556_CR34","doi-asserted-by":"publisher","first-page":"114356","DOI":"10.1016\/j.addr.2022.114356","volume":"186","author":"Q Xiao","year":"2022","unstructured":"Xiao Q, Zoulikha M, Qiu M, Teng C, Lin C, Li X, et al. The effects of protein corona on in vivo fate of nanocarriers. Adv Drug Deliv Rev. 2022;186:114356.","journal-title":"Adv Drug Deliv Rev"},{"key":"4556_CR35","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.molimm.2026.02.008","volume":"193","author":"Y Liu","year":"2026","unstructured":"Liu Y, Ma K, Jiang Z. Emerging molecular mechanisms of cGAS-STING activation and regulation. Mol Immunol. 2026;193:10\u201325.","journal-title":"Mol Immunol"},{"issue":"2","key":"4556_CR36","doi-asserted-by":"publisher","first-page":"101604","DOI":"10.1016\/j.jbc.2022.101604","volume":"298","author":"GC Walters","year":"2022","unstructured":"Walters GC, Usachev YM. MCU (mitochondrial Ca(2+) uniporter) makes the calcium go round. J Biol Chem. 2022;298(2):101604.","journal-title":"J Biol Chem"},{"issue":"4","key":"4556_CR37","doi-asserted-by":"publisher","first-page":"2123","DOI":"10.1128\/IAI.72.4.2123-2130.2004","volume":"72","author":"KA Ryan","year":"2004","unstructured":"Ryan KA, Smith MF Jr., Sanders MK, Ernst PB. Reactive oxygen and nitrogen species differentially regulate Toll-like receptor 4-mediated activation of NF-kappa B and interleukin-8 expression. Infect Immun. 2004;72(4):2123\u201330.","journal-title":"Infect Immun"},{"key":"4556_CR38","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.mad.2017.08.005","volume":"170","author":"G Nelson","year":"2018","unstructured":"Nelson G, Kucheryavenko O, Wordsworth J, von Zglinicki T. The senescent bystander effect is caused by ROS-activated NF-\u03baB signalling. Mech Ageing Dev. 2018;170:30\u20136.","journal-title":"Mech Ageing Dev"},{"issue":"1","key":"4556_CR39","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/s12967-023-04017-6","volume":"21","author":"L Galluzzi","year":"2023","unstructured":"Galluzzi L, Kepp O, Hett E, Kroemer G, Marincola FM. Immunogenic cell death in cancer: concept and therapeutic implications. J Transl Med. 2023;21(1):162.","journal-title":"J Transl Med"},{"issue":"21","key":"4556_CR40","doi-asserted-by":"publisher","first-page":"e202300662","DOI":"10.1002\/anie.202300662","volume":"62","author":"L Zhang","year":"2023","unstructured":"Zhang L, Montesdeoca N, Karges J, Xiao H. Immunogenic Cell Death Inducing Metal Complexes for Cancer Therapy. Angew Chem Int Ed Engl. 2023;62(21):e202300662.","journal-title":"Angew Chem Int Ed Engl"},{"issue":"11","key":"4556_CR41","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.1016\/j.scib.2025.03.015","volume":"70","author":"Q Wang","year":"2025","unstructured":"Wang Q, Wen Y, Bi B, Li K, Liu Y, Li B, et al. Oxygen\/sulfate radicals-generating CaS(2)O(8) nanosonosensitizers induce PANoptosis and calcium overload for enhanced peritoneal metastasis immunotherapy. Sci Bull (Beijing). 2025;70(11):1804\u201321.","journal-title":"Sci Bull (Beijing)"},{"issue":"1","key":"4556_CR42","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s12943-023-01790-2","volume":"22","author":"Q Wang","year":"2023","unstructured":"Wang Q, Liu P, Wen Y, Li K, Bi B, Li BB, et al. Metal-enriched HSP90 nanoinhibitor overcomes heat resistance in hyperthermic intraperitoneal chemotherapy used for peritoneal metastases. Mol Cancer. 2023;22(1):95.","journal-title":"Mol Cancer"},{"issue":"30","key":"4556_CR43","doi-asserted-by":"publisher","first-page":"e2203031","DOI":"10.1002\/advs.202203031","volume":"9","author":"J Zhao","year":"2022","unstructured":"Zhao J, Huang X, Liu P, Qiu M, Li B, Wen Y, et al. Engineering alendronate-composed iron nanochelator for efficient peritoneal carcinomatosis treatment. Adv Sci (Weinh). 2022;9(30):e2203031.","journal-title":"Adv Sci (Weinh)"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-026-04556-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04556-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04556-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T16:03:01Z","timestamp":1784044981000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12951-026-04556-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,19]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4556"],"URL":"https:\/\/doi.org\/10.1186\/s12951-026-04556-2","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,19]]},"assertion":[{"value":"22 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All animal experiments were approved by the Animal Care and Use Committee (TOPGM-IACUC-2025-0181) of Shenzhen TOP Biotechnology Co., Ltd.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"656"}}